Академический Документы
Профессиональный Документы
Культура Документы
Chang MH, You SL, Chen CJ, et al; Taiwan Hepatoma Study Group.
Decreased incidence of hepatocellular carcinoma in Hepatitis B vaccinees: a
20-year follow-up study. J Natl Cancer Inst 2009; 101:134855.
Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. Minimization of
Hepatitis B infection by a 25-year universal vaccination program. J Hepatol
2012; 57: 73035.
Wilson NS, Behrens GM, Lundie RJ, Smith CM, Waithman J, Young L, et al.
Systemic activation of dendritic cells by Toll-like receptor ligands or malaria
infection impairs cross-presentation and antiviral immunity. Nat Immunol
2006; 7:16572
34
Seeger C dan Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev
2000; 64:5168.
Longo DL, Kasper DL, Jameson JL, Fauci A, Hauser S, Loscalzo eds.
Centers for Disease Control and Prevention. 2014. Hepatitis B information for
health professionals: Hepatitis B FAQs for health professionals.
http://www.cdc.gov/hepatitis/HBV/index.htm. Diakses 20 Februari 2015.
Lok AS, McMahon BJ. Chronic Hepatitis B: update 2009. Hepatology. 2009;
50(3):661-2.
35
Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, et al.
National Institutes of Health Consensus Development Conference Statement:
management of Hepatitis B. Ann Intern Med 2009; 150(2):104-10.
Das A dan Maini MK. Innate and adaptive immune responses in Hepatitis B
virus infection. Dig Dis 2010; 28(1):126132.
New York State Department of Health. Hepatitis B virus. New York, NY: New
York State Department of Health; 2008. http://guideline.gov/content.aspx?
id=12812. Diakses 20 Februari 2015.
36
Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, et al. Factors
predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular
carcinoma. World J Gastroenterol 2011; 17(38):4258-70.
37
Abbas AK, Lichtman AH, dan Pillai S (eds) . Cellular and Molecular
Immunology. Edisi ke 8. Chapter 4 : 51-86. USA : Elsevier Inc; 2015.
Menne S, Tennant BC, Liu KH, Ascenzi MA, Baldwin BH, Bellezza CA, Cote
PJ, Zheng X, Wolfgang G, and Tumas D. Anti-viral efficacy and induction of
an antibody response against surface antigen with the TLR-7 agonist GS-9620
in the woodchuck model of chronic HBV infection. J Hepatol 2011; 54
(S1):S441.
Wang YI, et al.. Immunizations with hepatitis B viral antigens and a TLR-7/8
agonist adjuvant induce antigen-specific immune responses in HBV-transgenic
mice. International Journal of Infectious Diseases
2014; 29:3136.
38